Weiss Multi-Strategy Advisers’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-70,090	Closed	-$48K	–	930
2020 Q4	$48K	Sell	70,090 -989,966	-93%	-$2.11M	﹤0.01%	667
2020 Q3	$2.38M	Buy	1,060,056 +798,753	+306%	+$2.28M	0.06%	323
2020 Q2	$935K	Buy	261,303 +53,399	+26%	+$193K	0.03%	415
2020 Q1	$790K	Sell	207,904 -1,945,988	-90%	-$6.41M	0.03%	320
2019 Q4	$6.48M	Buy	+2,153,892	New	+$5.6M	0.11%	264

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Weiss Multi-Strategy Advisers's BMY.RT Position: Q1 2021 in Review

Weiss Multi-Strategy Advisers sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 70,090 shares — an estimated $48K sold.

Weiss Multi-Strategy Advisers first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $6.48M in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Weiss Multi-Strategy Advisers reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 70,090 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $48K.
Weiss Multi-Strategy Advisers first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
Weiss Multi-Strategy Advisers's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $6.48M in Q4 2019.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2021, filed 14 May 2021.